An Allysine-Conjugatable Probe for Fluorogenically Imaging Fibrosis
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c00404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Yilian Zhuang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, 866 Yuhangtang Street, H…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Program for Support of Top-notch Young Professionals, National Natural Science Foundation of China.
Abstract (Originalsprache)
Allysine, a pivotal biomarker in fibrogenesis, has prompted the development of various radioactive imaging probes. However, fluorogenic probes targeting allysine remain largely unexplored. Herein, by leveraging the equilibrium between the nonfluorescent spirocyclic and the fluorescent zwitterionic forms of rhodamine-cyanine hybrid fluorophores, we systematically fine-tuned the environmental sensitivity of this equilibrium toward the development of fluorogenic probes for fibrosis. The trick lies in modulating the nucleophilicity of the ortho-carboxyl group, which is terminated with a hydrazide group for allysine conjugation. Probe B2 was developed with this strategy, which featured an N-sulfonyl amide group and exhibited superior fibrosis-to-control imaging contrast. Initially presenting as nonfluorescent spirocyclic aggregates in aqueous solutions, B2 displayed a notable fluorogenic response upon conjugation with protein allysine through its hydrazide group, inducing deaggregation and switching to the fluorescent zwitterionic form. Probe B2 outperformed the traditional Masson stain in imaging contrast, achieving an about 260-2600-fold ratio for fibrosis-to-control detection depending on fibrosis severity. Furthermore, it demonstrated efficacy in evaluating antifibrosis drugs. Our results emphasize the potential of this fluorogenic probe as an alternative to conventional fibrosis detection methods. It emerges as a valuable tool for antifibrosis drug evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, 866 Yuhangtang Street, Hangzhou 310058, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Lingang Laboratory, Shanghai 201203, China.
- National Key Laboratory of Chinese Medicine Modernization, Innovation Center of Yangtze River Delta, Zhejiang University, Jiashan 314100, China.
ORCID-Profile: Yilian Zhuang, Xin Li
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Program for Support of Top-notch Young Professionals
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Program of Shanghai Academic Research Leader
Zitieren
APA
Zhuang, Y., Yin, T., Li, J., Zang, Y., & Li, X. (2024). An Allysine-Conjugatable Probe for Fluorogenically Imaging Fibrosis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c00404
Vancouver
Zhuang Y, Yin T, Li J, Zang Y, Li X. An Allysine-Conjugatable Probe for Fluorogenically Imaging Fibrosis. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c00404
BibTeX
@article{Zhuang2024,
author = {Zhuang, Yilian and Yin, Tao and Li, Jia and Zang, Yi and Li, Xin},
title = {An Allysine-Conjugatable Probe for Fluorogenically Imaging Fibrosis},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c00404}
}
EUVIMED